Emmaus Life Sciences, Inc.
EMMA
$0.016
$0.00053.23%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.39M | 1.26M | 1.53M | 1.71M | 2.55M |
| Total Receivables | 2.62M | 4.99M | 4.60M | 2.99M | 5.52M |
| Inventory | 1.64M | 1.61M | 1.63M | 1.53M | 1.71M |
| Prepaid Expenses | 894.00K | 530.00K | 607.00K | 853.00K | 1.13M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 226.00K | 817.00K | 654.00K | 762.00K | 596.00K |
| Total Current Assets | 6.77M | 9.20M | 9.01M | 7.84M | 11.51M |
|
|
|||||
| Total Current Assets | 6.77M | 9.20M | 9.01M | 7.84M | 11.51M |
| Net Property, Plant & Equipment | 1.58M | 1.77M | 1.96M | 2.14M | 2.40M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 222.00K | 312.00K | 308.00K | 310.00K | 296.00K |
| Total Assets | 23.60M | 27.34M | 25.94M | 29.54M | 35.18M |
|
|
|||||
| Total Accounts Payable | 594.00K | 578.00K | 1.69M | 1.50M | 518.00K |
| Total Accrued Expenses | 21.32M | 22.63M | 20.23M | 20.19M | 18.59M |
| Short-term Debt | 10.47M | 10.69M | 10.65M | 10.49M | 11.34M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 19.44M | 18.53M | 17.23M | 17.46M | 18.02M |
| Total Finance Division Other Current Liabilities | 11.74M | 11.70M | 14.22M | 12.79M | 13.04M |
| Total Other Current Liabilities | 11.74M | 11.70M | 14.22M | 12.79M | 13.04M |
| Total Current Liabilities | 63.56M | 64.13M | 64.03M | 62.43M | 61.51M |
|
|
|||||
| Total Current Liabilities | 63.56M | 64.13M | 64.03M | 62.43M | 61.51M |
| Long-Term Debt | 2.25M | 2.24M | 2.24M | 2.23M | 2.23M |
| Short-term Debt | 10.47M | 10.69M | 10.65M | 10.49M | 11.34M |
| Capital Leases | 815.00K | 1.08M | 1.32M | 1.56M | 1.84M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.47M | 13.68M | 15.37M | 16.97M | 17.36M |
| Total Liabilities | 80.08M | 81.12M | 82.95M | 83.19M | 82.94M |
|
|
|||||
| Common Stock & APIC | 225.96M | 225.93M | 225.90M | 225.57M | 225.40M |
| Retained Earnings | -262.58M | -260.83M | -262.65M | -260.47M | -256.12M |
| Treasury Stock & Other | -19.86M | -18.89M | -20.26M | -18.74M | -17.03M |
| Total Common Equity | -56.48M | -53.78M | -57.01M | -53.64M | -47.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -56.48M | -53.78M | -57.01M | -53.64M | -47.76M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -56.48M | -53.78M | -57.01M | -53.64M | -47.76M |
|
|
|||||